IMMUNOCHARGING

Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Sept 2023)

What this means for you

This application is over — abandoned 04 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90326590
Mark type
Stylized text
Filed
18 Nov 2020
Published for opposition
08 Jun 2021
Abandoned
04 Sept 2023
Attorney of record
Camille M. Miller

Goods and services

  • Class 001 — Chemicals: Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research
  • Class 005 — Pharmaceuticals: Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; surgical implants comprised of living tissue, namely, human amniotic membrane and human chorionic membrane intended for subsequent implantation; surgical implants comprised of living tissue, namely, human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use in the nature of biological preparations, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for treating cancer or other disease-associated antigen; pharmaceutical preparations for wounds, namely, biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; written instructional materials distributed in connection with the aforesaid goods packaged with the goods; biological products for medical use, namely, biological preparations in the nature of placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for treatment of cancer or other disease-associated antigen
  • Class 042 — Scientific and technological services: Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing technical writing and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biological research, namely, biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

Owner

Prosecution history

  • 05 Sept 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 04 Sept 2023 — ABANDONMENT - NO USE STATEMENT FILED
  • 29 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 27 Dec 2022 — SOU EXTENSION 3 GRANTED
  • 27 Dec 2022 — SOU EXTENSION 3 FILED
  • 27 Dec 2022 — SOU TEAS EXTENSION RECEIVED
  • 07 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 05 Jul 2022 — SOU EXTENSION 2 GRANTED
  • 05 Jul 2022 — SOU EXTENSION 2 FILED
  • 05 Jul 2022 — SOU TEAS EXTENSION RECEIVED
  • 05 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 03 Jan 2022 — SOU EXTENSION 1 GRANTED
  • 03 Jan 2022 — SOU EXTENSION 1 FILED
  • 03 Jan 2022 — SOU TEAS EXTENSION RECEIVED
  • 03 Aug 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT

View this trademark record on Marksy